Chris Headle serves as Vice President
– West Coast for Ken Clark International (KCI) from the firm’s
Newport Beach office in California. He joined KCI in 2000.
Headle is responsible for business development with clients of
KCI in Arizona; California; Colorado; Nevada; Oregon; Utah; and
Washington. His Industry focus includes Life Sciences (pharmaceutical,
medical, biological, diagnostic, consumer health and scientific
products as well as manufacturing, research and laboratory services);
Medical and Health Care Services; Consumer; Industrial, Chemicals
and Materials; and Advanced Technology. In serving his clients,
Headle often “teams” with KCI’s offices in North
America, Europe, Asia Pacific, Latin America and Middle East/Africa.
He also “teams” with KCI’s specialty practices
when appropriate. As often as possible, KCI’s geographic and
industry “expertise” is presented to clients.
Headle is accountable for the success of all search projects the
Western US. He leads search project planning discussions - local,
regional or global scope; in-near-outside the box recruiting targets;
and candidate qualifications including skills, knowledge, activities
and accomplishments. He supervises Researchers and Recruiters in
search project execution that includes: people and company research;
contacting and motivating of possible candidates; and screening
of potential candidates. Headle himself conducts performance-based
evaluations and management and leadership evaluations of finalist
candidates. Finally, he also coordinates employment offer negotiations
and final recruiting of the chosen candidate.
Prior to joining KCI, Headle was Vice President, Sales for B. Braun
Medical, a $3 billion medical products company. Prior to his role
at B.Braun, he served in virtually every commercial capacity during
his management career within parent companies IVAX and Kendall.
Headle began his career in industry as a Sales Representative with
McGaw, a division of American Hospital Supply Corporation.
Past KCI clients in the Western United States include: 1-800 CONTACTS;
Advanced Bionics; Advanced Cell Technology; Advanced Sterilization;
Advanced Tissue Science; Aesculap; Affymetrix; Agilent Technologies;
Align Technology; Allergan; Alphatec; ALZA; American Red Cross Services;
Ambion; Amgen; Angiotech; Avery Dennison; AviaraDx; Baxa; Becton
Dickinson; Biogen; Biolmagene; BioMarin; Bio-Rad; BioReliance; Biosense
Webster; Biosensors; Celera; Biosite; CB Richard Ellis; CardioGenesis;
Calypte Biomedical; Carl Zeiss; Celsion; Cerus; Cholestech; Cobalt;
Cordis; Corixa; Covidien; Cygnus; Cytec; DaVita; Dey; Dial; DirecTV;
DJO; Edwards Lifesciences; Elan; Genentech; Gen-Probe; Giant Industries;
Grifols Biologicals; Hycor; iCrete; ICI Paints; ICOS; Isis Pharmaceuticals;
Institute for OneWorld Health; Intuitive; James Hardie; KLA-Tencor;
Laserscope; LifePoint; Lifescan; Life Technologies; Matrixx Initiatives;
MDS; Medegen Medical; MedImmune; Medtronic; Mentor; Millipore; MKG
Imaging; Nanogen; Natura; Nektar; Neurocrine; Neutrogena; Newport;
North American Science Associates; Novartis; Ocular Sciences; Odyssey;
OKI Data; Pulse Engineering; Quintiles; Restoragen; Roche; Sangart;
Scios; Sequenom; Siemens; Spectrum Pharmaceuticals; Sunrise Medical;
SuperGen; Sybron Dental; Tanox; Thoratec; Toshiba; Verenius; Xenogen;
and Zila.
Headle has a Bachelor’s of Science degree in General Engineering
from the United States Military Academy at West Point.